Metabolic profile of women with PCOS in Brazil : a systematic review and meta-analysis
Main Author: | |
---|---|
Publication Date: | 2021 |
Other Authors: | , , , |
Format: | Article |
Language: | eng |
Source: | Repositório Institucional da UFRGS |
Download full: | http://hdl.handle.net/10183/219602 |
Summary: | Background: Polycystic ovary syndrome (PCOS) is a common endocrine disease affecting women of reproductive age and associated with reproductive and metabolic dysfunction. Few studies are available regarding metabolic traits in Brazilian women with PCOS. The aim of this systematic review and meta-analysis was to summarize the available evidence regarding metabolic traits and comorbidities in Brazilian women with polycystic ovary syndrome (PCOS). Methods: We systematically searched PubMed, Cochrane Central Register of Controlled Trials, and Embase for cross-sectional, case–control, or cohort studies focusing on populations of different regions from Brazil, published until July 31, 2019. Studies were selected if they reported PCOS diagnostic criteria. Studies without a control group were included if they presented relevant metabolic data. Results: Of 4856 studies initially identified, 27 were included in the systematic review and 12 were included in the meta-analysis, for a total of 995 women with PCOS defined by Rotterdam criteria and 2275 controls from different regions of Brazil. Obesity, metabolic syndrome and IGT were prevalent, and standard mean differences for BMI (SMD 0.67, 95% CI, 0.29, 1.05), waist circumference (SMD 0.22, 95% CI 0.02, 0.41), systolic (SMD 0.66, 95% CI 0.30, 1.01) and diastolic blood pressure (SMD 0.55, 95% CI 0.24, 0.87), glucose (SMD 0.21, 95% CI 0.04, 0.38) and HOMA (SMD 0.78, 95% CI 0.52, 1.04) were significantly higher in Brazilian women with PCOS compared to controls. Lipid profile was more adverse in PCOS vs. non-PCOS women. Between-study heterogeneities were low/moderate for glucose and HOMA and moderate/high for the other variables. Conclusions: The data of this systematic review and meta-analysis indicate that Brazilian women with PCOS have a worse metabolic profile than women without PCOS with no important regional differences. The prevalence of metabolic changes is intermediate in Brazil vs. other countries. |
id |
UFRGS-2_25d7f51d7c73b718e75523efbb6d17c4 |
---|---|
oai_identifier_str |
oai:www.lume.ufrgs.br:10183/219602 |
network_acronym_str |
UFRGS-2 |
network_name_str |
Repositório Institucional da UFRGS |
repository_id_str |
|
spelling |
Spritzer, Poli MaraRamos, Ramon BossardiMarchesan, Lucas BandeiraOliveira, Mônica deCarmina, Enrico2021-04-08T04:17:28Z20211758-5996http://hdl.handle.net/10183/219602001123721Background: Polycystic ovary syndrome (PCOS) is a common endocrine disease affecting women of reproductive age and associated with reproductive and metabolic dysfunction. Few studies are available regarding metabolic traits in Brazilian women with PCOS. The aim of this systematic review and meta-analysis was to summarize the available evidence regarding metabolic traits and comorbidities in Brazilian women with polycystic ovary syndrome (PCOS). Methods: We systematically searched PubMed, Cochrane Central Register of Controlled Trials, and Embase for cross-sectional, case–control, or cohort studies focusing on populations of different regions from Brazil, published until July 31, 2019. Studies were selected if they reported PCOS diagnostic criteria. Studies without a control group were included if they presented relevant metabolic data. Results: Of 4856 studies initially identified, 27 were included in the systematic review and 12 were included in the meta-analysis, for a total of 995 women with PCOS defined by Rotterdam criteria and 2275 controls from different regions of Brazil. Obesity, metabolic syndrome and IGT were prevalent, and standard mean differences for BMI (SMD 0.67, 95% CI, 0.29, 1.05), waist circumference (SMD 0.22, 95% CI 0.02, 0.41), systolic (SMD 0.66, 95% CI 0.30, 1.01) and diastolic blood pressure (SMD 0.55, 95% CI 0.24, 0.87), glucose (SMD 0.21, 95% CI 0.04, 0.38) and HOMA (SMD 0.78, 95% CI 0.52, 1.04) were significantly higher in Brazilian women with PCOS compared to controls. Lipid profile was more adverse in PCOS vs. non-PCOS women. Between-study heterogeneities were low/moderate for glucose and HOMA and moderate/high for the other variables. Conclusions: The data of this systematic review and meta-analysis indicate that Brazilian women with PCOS have a worse metabolic profile than women without PCOS with no important regional differences. The prevalence of metabolic changes is intermediate in Brazil vs. other countries.application/pdfengDiabetology & metabolic syndrome. [London]. Vol. 13 (2021), 18, 16 p.Síndrome do ovário policísticoMetabolismoMulheresRevisão sistemáticaPolycystic ovary syndromeObesityBlood pressureInsulin resistanceMetabolic abnormalitiesBrazilMetabolic profile of women with PCOS in Brazil : a systematic review and meta-analysisEstrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001123721.pdf.txt001123721.pdf.txtExtracted Texttext/plain58851http://www.lume.ufrgs.br/bitstream/10183/219602/2/001123721.pdf.txt69824a6684b9a2ac97a1e1d2462f6df2MD52ORIGINAL001123721.pdfTexto completo (inglês)application/pdf1629511http://www.lume.ufrgs.br/bitstream/10183/219602/1/001123721.pdf7140f003ebbba1ecc6f2845a972ca7c9MD5110183/2196022021-05-07 04:58:53.18247oai:www.lume.ufrgs.br:10183/219602Repositório InstitucionalPUBhttps://lume.ufrgs.br/oai/requestlume@ufrgs.bropendoar:2021-05-07T07:58:53Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false |
dc.title.pt_BR.fl_str_mv |
Metabolic profile of women with PCOS in Brazil : a systematic review and meta-analysis |
title |
Metabolic profile of women with PCOS in Brazil : a systematic review and meta-analysis |
spellingShingle |
Metabolic profile of women with PCOS in Brazil : a systematic review and meta-analysis Spritzer, Poli Mara Síndrome do ovário policístico Metabolismo Mulheres Revisão sistemática Polycystic ovary syndrome Obesity Blood pressure Insulin resistance Metabolic abnormalities Brazil |
title_short |
Metabolic profile of women with PCOS in Brazil : a systematic review and meta-analysis |
title_full |
Metabolic profile of women with PCOS in Brazil : a systematic review and meta-analysis |
title_fullStr |
Metabolic profile of women with PCOS in Brazil : a systematic review and meta-analysis |
title_full_unstemmed |
Metabolic profile of women with PCOS in Brazil : a systematic review and meta-analysis |
title_sort |
Metabolic profile of women with PCOS in Brazil : a systematic review and meta-analysis |
author |
Spritzer, Poli Mara |
author_facet |
Spritzer, Poli Mara Ramos, Ramon Bossardi Marchesan, Lucas Bandeira Oliveira, Mônica de Carmina, Enrico |
author_role |
author |
author2 |
Ramos, Ramon Bossardi Marchesan, Lucas Bandeira Oliveira, Mônica de Carmina, Enrico |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Spritzer, Poli Mara Ramos, Ramon Bossardi Marchesan, Lucas Bandeira Oliveira, Mônica de Carmina, Enrico |
dc.subject.por.fl_str_mv |
Síndrome do ovário policístico Metabolismo Mulheres Revisão sistemática |
topic |
Síndrome do ovário policístico Metabolismo Mulheres Revisão sistemática Polycystic ovary syndrome Obesity Blood pressure Insulin resistance Metabolic abnormalities Brazil |
dc.subject.eng.fl_str_mv |
Polycystic ovary syndrome Obesity Blood pressure Insulin resistance Metabolic abnormalities Brazil |
description |
Background: Polycystic ovary syndrome (PCOS) is a common endocrine disease affecting women of reproductive age and associated with reproductive and metabolic dysfunction. Few studies are available regarding metabolic traits in Brazilian women with PCOS. The aim of this systematic review and meta-analysis was to summarize the available evidence regarding metabolic traits and comorbidities in Brazilian women with polycystic ovary syndrome (PCOS). Methods: We systematically searched PubMed, Cochrane Central Register of Controlled Trials, and Embase for cross-sectional, case–control, or cohort studies focusing on populations of different regions from Brazil, published until July 31, 2019. Studies were selected if they reported PCOS diagnostic criteria. Studies without a control group were included if they presented relevant metabolic data. Results: Of 4856 studies initially identified, 27 were included in the systematic review and 12 were included in the meta-analysis, for a total of 995 women with PCOS defined by Rotterdam criteria and 2275 controls from different regions of Brazil. Obesity, metabolic syndrome and IGT were prevalent, and standard mean differences for BMI (SMD 0.67, 95% CI, 0.29, 1.05), waist circumference (SMD 0.22, 95% CI 0.02, 0.41), systolic (SMD 0.66, 95% CI 0.30, 1.01) and diastolic blood pressure (SMD 0.55, 95% CI 0.24, 0.87), glucose (SMD 0.21, 95% CI 0.04, 0.38) and HOMA (SMD 0.78, 95% CI 0.52, 1.04) were significantly higher in Brazilian women with PCOS compared to controls. Lipid profile was more adverse in PCOS vs. non-PCOS women. Between-study heterogeneities were low/moderate for glucose and HOMA and moderate/high for the other variables. Conclusions: The data of this systematic review and meta-analysis indicate that Brazilian women with PCOS have a worse metabolic profile than women without PCOS with no important regional differences. The prevalence of metabolic changes is intermediate in Brazil vs. other countries. |
publishDate |
2021 |
dc.date.accessioned.fl_str_mv |
2021-04-08T04:17:28Z |
dc.date.issued.fl_str_mv |
2021 |
dc.type.driver.fl_str_mv |
Estrangeiro info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10183/219602 |
dc.identifier.issn.pt_BR.fl_str_mv |
1758-5996 |
dc.identifier.nrb.pt_BR.fl_str_mv |
001123721 |
identifier_str_mv |
1758-5996 001123721 |
url |
http://hdl.handle.net/10183/219602 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.pt_BR.fl_str_mv |
Diabetology & metabolic syndrome. [London]. Vol. 13 (2021), 18, 16 p. |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFRGS instname:Universidade Federal do Rio Grande do Sul (UFRGS) instacron:UFRGS |
instname_str |
Universidade Federal do Rio Grande do Sul (UFRGS) |
instacron_str |
UFRGS |
institution |
UFRGS |
reponame_str |
Repositório Institucional da UFRGS |
collection |
Repositório Institucional da UFRGS |
bitstream.url.fl_str_mv |
http://www.lume.ufrgs.br/bitstream/10183/219602/2/001123721.pdf.txt http://www.lume.ufrgs.br/bitstream/10183/219602/1/001123721.pdf |
bitstream.checksum.fl_str_mv |
69824a6684b9a2ac97a1e1d2462f6df2 7140f003ebbba1ecc6f2845a972ca7c9 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS) |
repository.mail.fl_str_mv |
lume@ufrgs.br |
_version_ |
1834472514577760256 |